title: A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.
authors.forename: Hugh A
authors.initials: HA
authors.lastname: Sampson
authors.forename: Donald Y M
authors.initials: DY
authors.lastname: Leung
authors.forename: A Wesley
authors.initials: AW
authors.lastname: Burks
authors.forename: Gideon
authors.initials: G
authors.lastname: Lack
authors.forename: Sami L
authors.initials: SL
authors.lastname: Bahna
authors.forename: Stacie M
authors.initials: SM
authors.lastname: Jones
authors.forename: Dennis A
authors.initials: DA
authors.lastname: Wong
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000485:Allergens / Q000008:administration & dosage*; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D010367:Arachis / Q000276:immunology*; D002648:Child; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab; D021183:Peanut Hypersensitivity / Q000276:immunology / Q000628:therapy*; D010940:Plant Proteins / Q000008:administration & dosage* / Q000276:immunology; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000485:Allergens; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D010940:Plant Proteins; D000069444:Omalizumab